Clinical Trials Browser

Phase 1/2 × Squamous Cell Carcinoma of Head and Neck × zalutumumab × Clear all

NCT01054625 2023-08-03

Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Phase 1/2 Completed

31 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00093041 2023-06-28

Zalutumumab in Head and Neck Cancer

Phase 1/2 Completed

28 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms